Our results showed that CAND1 might be involved in the activation of the androgen and estrogen signaling pathways in ERα-positive breast cancer, as the genes that strongly correlate with CAND1 in ERα-positive breast cancer were involved in activating these pathways. This evidence concerns the gene CAND1 and breast carcinoma.